Saudi Arabia SFDA Medical Device Registration & MDMA
Your Partner for Successful Market Access in Saudi Arabia
We help medical device, IVD and software manufacturers achieve SFDA registration, MDMA approval and long-term compliance in Saudi Arabia through expert strategy, robust documentation and end-to-end regulatory support.
SFDA Regulatory Expertise
Experienced team with deep knowledge of Saudi regulations
End-to-End Support
From qualification to MDMA approval & post-market vigilance
Local AR Representation
Licensed Authorized Representative in the Kingdom
Faster Approvals & Entry
Proven submission strategies for accelerated MDMA issuance
Compliance You Can Trust
Strict adherence to MDS-REQ 1 & Medical Devices Law
Complete SFDA Regulatory Services Suite
1. SFDA Regulatory Strategy & Product Classification
- •Product classification (Class A, B, C, D) based on risk rules
- •Identification of applicable guidance & technical requirements
- •Regulatory roadmap with timelines and deliverables
- •Gap assessment & compliance strategy under MDS-REQ 1
2. MDMA Application & Technical File Strategy
- •Application form & administrative data in GHAD
- •Device description & intended use alignment
- •Risk management file (ISO 14971) & Essential Principles
- •QMS certificate (ISO 13485) & Free Sale Certificate (FSC)
3. Saudi Authorized Representative Services
- •Legal representation & official SFDA correspondence
- •Submission, follow-up & tracking in GHAD portal
- •Receipt of official communications & technical queries
- •Liaison during technical review, audits & renewals
4. Medical Device Establishment Licensing & Local Supply Chain
- •Establishment license (Manufacturer / Importer / Distributor)
- •Local site registration & approval under MDS-REQ 9
- •QMS site compliance & warehouse storage review
- •Local supply chain traceability & compliance
5. Technical Documentation & Essential Principles
- •Device description, intended purpose & specifications
- •Design & manufacturing process information
- •Essential Principles checklist & verification evidence
- •Biocompatibility, sterilization, electrical safety & EMC
6. Testing Strategy & Laboratory Coordination
- •Test plan based on risk, standards & device type
- •Coordination with SFDA-recognized accredited labs
- •Electrical safety, EMC, performance & reliability
- •Biocompatibility & sterilization validation review
7. IVD Registration & Performance Evidence
- •IVD classification (Class A, B, C, D) by risk rules
- •Analytical performance studies (LoD, specificity, precision)
- •Clinical performance evaluation & comparator data
- •Arabic labeling & Instructions for Use (IFU)
8. SaMD / Software / AI & Cybersecurity
- •SaMD classification & GHAD submission strategy
- •Software life cycle documentation (IEC 62304)
- •Cybersecurity & data protection risk management
- •AI/ML model transparency & clinical validation
9. Labeling, IFU, UDI & Advertising Compliance
- •Arabic labeling & IFU translation preparation
- •Saudi-DI UDI assignment & database submission
- •Packaging compliance & symbol standardisation
- •Advertising & promotion compliance (MDS-REQ 8)
10. Post-Market Surveillance, Vigilance & FSCA
- •PMS plan development & customer feedback tracking
- •Adverse event reporting to SFDA vigilance portal
- •Field Safety Corrective Actions (FSCA) & Recall support
- •Trend analysis & Annual PMS report preparation
11. SFDA Inspection & QMS Readiness
- •Pre-audit gap assessment & mock inspections
- •QMS readiness (MDS-REQ 10 / ISO 13485)
- •Internal audit & management review support
- •Supplier & CAPA audit readiness & close-out
12. Changes, Variations, Renewal & Lifecycle Support
- •Change classification & regulatory impact assessment
- •Variation submission via GHAD portal
- •MDMA registration & establishment license renewal
- •Technical file updates & lifecycle maintenance
13. SFDA Queries, Deficiency Response & Technical Review
- •Handling SFDA inquiries & deficiency letters
- •Deficiency response & technical rebuttal drafting
- •Technical review meetings & liaison support
- •Document re-submission & time-bound closure
Our End-to-End SFDA Regulatory Process
Strategy & Classification
Confirm product status, intended purpose, classification and Saudi market-access route.
Dossier Preparation
Compile technical file, Essential Principles mapping, QMS and Arabic translations.
Submission to SFDA
Submit MDMA application via unified GHAD electronic portal through Saudi AR.
SFDA Review & Queries
Respond to technical questions, deficiency letters and inspection observations.
Approval (MDMA)
Receive official Medical Devices Marketing Authorization certificate from SFDA.
Post-Market Compliance
Maintain vigilance, Saudi-DI UDI, FSCA, renewals, and lifecycle change control.
Why Choose NKB Regovanta for Saudi Arabia?
Ready to Enter the Saudi Market?
Partner with NKB Regovanta for seamless SFDA registration, compliance and market success.
Contact Our Saudi Experts Today!Comprehensive SFDA Regulatory & MDMA Access
Explore our in-depth methodologies, strategic frameworks, and regulatory decision pathways for the Kingdom of Saudi Arabia.
1. SFDA Regulatory Strategy & Product Classification
Saudi Arabia uses a risk-based classification framework for medical devices. Devices other than IVDs are classified as Class A, B, C or D, with additional distinctions for certain Class A sterile, measuring and reusable surgical instruments. IVDs are also classified from Class A through Class D based on individual and public-health risk.
Classification Drivers
- • Product qualification and regulatory-status assessment
- • Intended purpose, indication and claims review
- • Class A, B, C and D classification assessment for medical devices
- • IVD Class A-D classification assessment
- • Accessory, system and combination considerations
Our Support Scope
- • Software and SaMD classification strategy
- • Classification-rule justification
- • Regulatory evidence roadmap from classification through MDMA
- • Assessment of whether a change in intended purpose or technology affects classification
Regulatory Principle:
We do not stop at assigning a class. We trace the classification into the technical documentation, level of evidence, QMS expectations, local regulatory structure and post-market controls that must follow.
2. MDMA Application & Technical File Strategy
The Medical Devices Marketing Authorization is the principal SFDA market-authorization route for medical devices intended to be supplied in Saudi Arabia. The application is supported by a technical file demonstrating conformity with SFDA requirements and the essential principles of safety and performance.
MDMA Preparation
- • MDMA route assessment and application readiness
- • Technical-file assessment strategy under MDS-REQ 1
- • Device family / grouping assessment
- • Manufacturer and Authorized Representative data alignment
- • Declaration of conformity and QMS evidence review
Submission & Follow-up
- • Essential Principles evidence mapping
- • Risk-management and clinical evidence review
- • Labeling and Arabic IFU alignment
- • Response to SFDA technical questions and requests for additional information
- • Authorization-record review following approval
MDMA Strategy Principle:
We do not begin with the submission portal. We begin with the regulatory basis that makes the MDMA application defensible.
Frequently Asked Questions (SFDA & Saudi Arabia)
Key questions manufacturers ask when registering medical devices, IVDs and SaMD in the Kingdom of Saudi Arabia.
What is MDMA in Saudi Arabia?
MDMA is the Saudi Food and Drug Authority marketing authorization for medical devices that are permitted to be placed on the Saudi market. The route is supported by device classification, technical documentation, safety and performance evidence and the applicable local regulatory structure.
How are medical devices classified in Saudi Arabia?
SFDA uses a risk-based Class A, B, C and D framework. The manufacturer is responsible for determining the applicable class and rule, considering intended purpose, risk, duration, invasiveness and other device characteristics.
How are IVDs classified in Saudi Arabia?
IVD medical devices are classified as Class A, B, C or D based on individual and public-health risk. The intended purpose, analyte or marker, clinical context and target population are central to the classification.
Does an overseas manufacturer need a Saudi Authorized Representative?
A manufacturer established outside Saudi Arabia must operate through the applicable Saudi Authorized Representative framework. The AR is a Saudi-based legal person authorized to represent the manufacturer with respect to the Medical Devices Law and its Implementing Regulation.
Is an Authorized Representative the same as an importer?
No. The Authorized Representative is the manufacturer's legal regulatory representative in the Kingdom, while importers and distributors perform supply-chain activities and have their own establishment and compliance obligations under MDS-REQ 9.
What is included in the MDMA technical file?
The technical file can include device description, intended purpose, classification rationale, essential-principles evidence, risk management, verification and validation, clinical or performance evidence, QMS information, labeling and other product-specific evidence required by MDS-REQ 1.
Can NKB Regovanta coordinate testing laboratories?
Yes. Where external testing is required, we can help define the regulatory testing strategy, coordinate with established laboratories, review study protocols and assess resulting reports for use in the Saudi regulatory dossier.
Can an existing EU or FDA dossier be reused for Saudi Arabia?
Existing international evidence may often be leveraged, but it should be mapped against SFDA requirements, the Saudi classification, intended purpose, essential principles, local labeling and current technical-file expectations.
Does SFDA regulate post-market safety after MDMA approval?
Yes. SFDA monitors devices throughout the lifecycle. Manufacturers and local regulatory stakeholders must maintain systems for complaints, incidents, adverse-event assessment, field safety corrective actions and other post-market obligations.
Can changes after approval affect the MDMA?
Yes. Changes to intended purpose, design, software, manufacturing, suppliers, sterilization, labeling, performance evidence or local representation may affect the technical file or regulatory record and should be assessed before implementation.
Does SFDA inspect medical-device establishments?
Yes. SFDA has requirements for establishment licensing, inspections and quality-management systems (MDS-REQ 10). The inspection scope depends on the establishment activity and applicable regulatory requirements.
Are medical-device advertisements regulated in Saudi Arabia?
Yes. Medical-device advertising and awareness/charitable campaigns are subject to SFDA controls (MDS-REQ 8), and promotional claims should remain consistent with the authorized intended purpose and supporting evidence.
Your Regulatory Partner for Saudi Market Access
Whether you are classifying a new device, appointing a Saudi Authorized Representative, preparing an MDMA technical file, coordinating testing, responding to SFDA questions or maintaining post-market compliance, NKB Regovanta supports the regulatory lifecycle from strategy through ongoing market maintenance.